Neuron-Specific Enolase (NSE) as a Biomarker for Autistic Spectrum Disease (ASD).

ABSTRACT: Autistic spectrum disease (ASD) is an increasingly common diagnosis nowadays with a prevalence of 1-2% in most countries. Its complex causality-a combination of genetic, immune, metabolic, and environmental factors-is translated into pleiomorphic developmental disorders of various severity, which have two main aspects in common: repetitive, restrictive behaviors and difficulties in social interaction varying from awkward habits and verbalization to a complete lack of interest for the outside world. The wide variety of ASD causes also makes it very difficult to find a common denominator-a disease biomarker and medication-and currently, there is no commonly used diagnostic and therapeutic strategy besides clinical evaluation and psychotherapy. In the CORDUS clinical study, we have administer

SUBMITTER: Stancioiu F 

PROVIDER: S-EPMC10455327 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature